Galectin Therapeutics Inc (GALT)
3.37
+0.03
(+0.90%)
USD |
NASDAQ |
May 06, 10:28
Galectin Therapeutics Cash from Operations (TTM): -32.96M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -32.96M |
| September 30, 2023 | -35.50M |
| June 30, 2023 | -36.21M |
| March 31, 2023 | -33.81M |
| December 31, 2022 | -31.06M |
| September 30, 2022 | -30.77M |
| June 30, 2022 | -27.42M |
| March 31, 2022 | -25.97M |
| December 31, 2021 | -24.31M |
| September 30, 2021 | -22.77M |
| June 30, 2021 | -25.98M |
| March 31, 2021 | -22.61M |
| December 31, 2020 | -20.60M |
| September 30, 2020 | -18.95M |
| June 30, 2020 | -12.21M |
| March 31, 2020 | -11.94M |
| December 31, 2019 | -10.85M |
| September 30, 2019 | -9.096M |
| June 30, 2019 | -9.198M |
| March 31, 2019 | -9.947M |
| December 31, 2018 | -10.18M |
| September 30, 2018 | -12.08M |
| June 30, 2018 | -13.62M |
| March 31, 2018 | -15.54M |
| December 31, 2017 | -15.89M |
| Date | Value |
|---|---|
| September 30, 2017 | -16.85M |
| June 30, 2017 | -17.17M |
| March 31, 2017 | -16.78M |
| December 31, 2016 | -16.41M |
| September 30, 2016 | -16.14M |
| June 30, 2016 | -17.78M |
| March 31, 2016 | -16.16M |
| December 31, 2015 | -16.98M |
| September 30, 2015 | -15.50M |
| June 30, 2015 | -13.69M |
| March 31, 2015 | -13.12M |
| December 31, 2014 | -12.43M |
| September 30, 2014 | -10.96M |
| June 30, 2014 | -9.16M |
| March 31, 2014 | -8.68M |
| December 31, 2013 | -7.484M |
| September 30, 2013 | -7.589M |
| June 30, 2013 | -8.185M |
| March 31, 2013 | -8.437M |
| December 31, 2012 | -7.50M |
| September 30, 2012 | -7.291M |
| June 30, 2012 | -6.463M |
| March 31, 2012 | -5.795M |
| December 31, 2011 | -5.676M |
| September 30, 2011 | -4.717M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-36.21M
Minimum
Jun 2023
-9.096M
Maximum
Sep 2019
-23.27M
Average
-24.31M
Median
Dec 2021
Cash from Operations (TTM) Benchmarks
| Madrigal Pharmaceuticals Inc | -324.23M |
| Viking Therapeutics Inc | -54.87M |
| 89bio Inc | -129.19M |
| Terns Pharmaceuticals Inc | -67.39M |
| Enanta Pharmaceuticals Inc | -92.50M |